HLA-B*58:01 and Risk of Allopurinol-Induced Severe Cutaneous Adverse Reactions in the US

These findings suggest that although HLA-B*58:01 was found to be associated with allopurinol-induced SCARs, generalizing findings from previous studies, the allele was absent in more than one-third of the patient cohort and is therefore an incomplete indicator of risk. Importantly, in the US allopurinol-induced SCAR cohort, HLA-A*34:02 was found to be a second independent genetic risk factor for allopurinol-induced SCARs. These findings underscore the need to conduct population-based studies that both reproduce known and uncover novel HLA associations to reduce harm through contributions to screening, risk stratification, and diagnosis.

Authors

Institutions

Publication Details

Journal
JAMA Dermatology
Published
2025-10-29
DOI
https://doi.org/10.1001/jamadermatol.2025.4240
Citations
2
Primary Topic
Drug-Induced Adverse Reactions
Type
article
Field-Weighted Citation Impact
2.79
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

HLA-B*58:01 and Risk of Allopurinol-Induced Severe Cutaneous Adverse Reactions in the US

Kristina Williams, Chelsea N. Campbell, Michelle Goh, Dana King et al.
2 citations
JAMA Dermatology
Drug-Induced Adverse Reactions
2.79
article

HLA-B*58:01 and Risk of Allopurinol-Induced Severe Cutaneous Adverse Reactions in the US

Kristina Williams, Chelsea N. Campbell, Michelle Goh, Dana King, Suman Pakala, Aaron M. Drucker, Elizabeth Ergen, Robert G. Micheletti, Matthew S. Krantz, Benjamin Harris Kaffenberger, Rama Gangula, Michelle Martin‐Pozo, Elizabeth Williams, Rebecca Lee, Aili Yu, April O’Connor, Elizabeth J. P. Phillips, Kelby Mahan, Amy Palubinksy, Roni Dodiuk Gad
article en
2 citations

Abstract

These findings suggest that although HLA-B*58:01 was found to be associated with allopurinol-induced SCARs, generalizing findings from previous studies, the allele was absent in more than one-third of the patient cohort and is therefore an incomplete indicator of risk. Importantly, in the US allopurinol-induced SCAR cohort, HLA-A*34:02 was found to be a second independent genetic risk factor for allopurinol-induced SCARs. These findings underscore the need to conduct population-based studies that both reproduce known and uncover novel HLA associations to reduce harm through contributions to screening, risk stratification, and diagnosis.

JAMA DermatologyVol. 161(12)
Johnson & Johnson (United States) (US), Vanderbilt University Medical Center (US)
Openalex Percentile: Top 8%
Drug-Induced Adverse Reactions
2.79
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.